Flo Axiom
A bioprocessing technology company developing novel downstream purification materials and workflows that improve the efficiency, cost and scalability of biologics manufacturing.
How the company was formed, and what it is building.
Flo Axiom (formerly BioProSep) is a bioprocessing technology company developing novel downstream purification materials and workflows to improve the efficiency, cost and scalability of biologics manufacturing. The platform is designed to integrate into existing pharmaceutical manufacturing processes, with applications across biologics and advanced therapies.
The thesis is a capital‑efficient enabling platform addressing a critical bottleneck in biologics manufacturing — with potential to generate earlier revenue through research‑use and process‑development applications, while supporting Australian sovereign capability and reducing reliance on offshore purification technologies.
- Founded
- 2026
- Origin
- Griffith University
- Sector
- Bioprocessing
- Modality
- Downstream purification · Biologics manufacturing
Founders and key team.
Where the programme is now, and what comes next.
- Now
- Benchmarking and validation work with external partners. Manufacturing scalability being de‑risked.